ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Research Reagent/BOC-TYR(TBU)-AIB-OH
C22H34N2O6
422.5 g/mol
Research Reagent

BOC-TYR(TBU)-AIB-OH

CAS2639221-78-4
Category
Research Reagent
Compound Class
Peptide
Primary Use
Research Compound

BOC-TYR(TBU)-AIB-OH is a research reagent commonly employed as a peptide synthesis intermediate. It features tert-butyl-based protecting groups and is used in laboratory settings for constructing modified peptides.

peptide synthesis intermediateresearch reagent for peptide chemistry

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing BOC-TYR(TBU)-AIB-OH?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

SimilarStructure SimilarSimilarity 0.76

Boc-O-tert-butyl-L-tyrosine

CAS47375-34-8

pharmaceutical intermediate

ApplicationSame Use

N-Cbz-L-homoserine lactone

CAS35677-89-5

research compound

ApplicationSame Use

2-tert-Butoxycarbonylamino-4-carbamoylbutyric acid 4-nitrophenyl ester

CAS15387-45-8

research compound

ReferenceSame Category

1-(1-benzothiophen-4-yl)-4-nitrosopiperazine

CAS2639426-95-0

research compound

ReferenceSame Category

3-Methoxy-2-methylpyridine

CAS26395-26-6

research compound

ReferenceSame Category

Sulfur trioxide pyridine complex

CAS26412-87-3

research compound

ReferenceSame Category

2,2-bis(4-chlorophenyl)ethanol

CAS2642-82-2

research compound

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

2-methyl-2-[[(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-[4-[(2-methylpropan-2-yl)oxy]phenyl]propanoyl]amino]propanoic acid

InChIKey

NFZUXALUIGHTML-INIZCTEOSA-N

SMILES

CC(C)(C)OC1=CC=C(C=C1)C[C@@H](C(=O)NC(C)(C)C(=O)O)NC(=O)OC(C)(C)C

Synonyms (3)
  • BOC-TYR(TBU)-AIB-OH

Sourcing BOC-TYR(TBU)-AIB-OH?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→